Companies

Sangamo Therapeutics Inc

NASDAQ: SGMO
$0.07
▲ $0.00 (+0.00%) today
Markets closed · 6:14pm ET

SGMO Coverage

Page 3
7:11am ET
Investing

Pre-Market Stock News (June 19, 2007)

(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement in overall survival.(BAY) Bayer raised guidance on Schering integration.(BMY) Bristol-Myers: FDA Grants…

Douglas A. McIntyre